High blood pressure linked to common heart valve disorder | University of Oxford

High blood pressure linked to common heart valve disorder

18 October 2017

For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University of Oxford.

The study, published in the journal PLOS Medicine, followed 5.5 million adults in the UK over 10 years. It found that higher blood pressure in early life was associated with a significantly greater future risk of mitral regurgitation, a condition which makes the heart less efficient at pumping blood around the body, and in severe cases can lead to heart failure.

“Our research suggests this common and disabling valve disorder is not an inevitable consequence of ageing, as previously assumed, but may be preventable,” said Professor Kazem Rahimi, lead author of the study and deputy director of The George Institute UK.

“Given the large and growing burden of mitral valve disease, particularly among older people, we believe these findings are likely to have significant implications for medical policy and practice around the world.”

Mitral regurgitation leads to a backflow of blood into the heart, causing symptoms such as shortness of breath, tiredness, dizziness and chest pain. It is more common in older people, and may be associated with a greater risk of mortality.

Peter Williams, 59, of Oxfordshire, experienced the condition before having surgery to repair his mitral valve in 2016.

“I’ve always been an active person, but it slowed me down a lot,” he said. “I was tired and short of breath, and struggling to walk distances that wouldn’t normally have bothered me. My breathing was so noisy at night that it actually woke me up.”

Despite significant advances in the understanding of valve disease, mitral regurgitation has until now been largely considered a degenerative disorder, resulting from a weakening of the valve over time due to ‘wear and tear’.

This has led medical practitioners to focus on treatment – namely surgery to repair or replace the valve – rather than prevention. The new study suggests further research is needed to test whether lowering blood pressure – through exercise, diet or blood pressure-lowering drugs - could reduce the risk of the disorder occurring.

“With worldwide ageing and population growth, we are likely to see an increasing number of cases of this condition,” said Professor Rahimi. “We need to find effective and affordable measures to tackle it, and our study suggests one possible avenue for prevention, by reducing high blood pressure.”

The study was funded by the Oxford Martin School and the National Institute for Health Research through the NIHR Oxford Biomedical Research Centre and a NIHR Career Development Fellowship.

The paper in PLOS Medicine will be freely available from this link: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002404

Media enquiries

Emma Feeny
Senior Advocacy Advisor
The George Institute for Global Health, University of Oxford
efeeny@georgeinstitute.org

I am travelling to Australia during the embargo period, but will be contactable via email and will respond as soon as I can.

Professor Rahimi may also be contacted directly: kazem.rahimi@georgeinstitute.ox.ac.uk

About Professor Kazem Rahimi (@kazemr)
Kazem Rahimi is an Associate Professor of Cardiovascular Medicine at the University of Oxford. He is a cardiologist, epidemiologist and health services researcher with an interest in the prevention and management of chronic diseases. He is the Director of the Oxford Martin programme on Deep Medicine, which is using some of the largest and most complex biomedical datasets that have ever been collected to generate insights into complex disease patterns, risk trajectories and treatment effects. As the Deputy Director of The George Institute UK, he leads a team of researchers that are working towards the identification of practical and affordable solutions that address the unmet healthcare needs of vulnerable or disadvantaged populations globally.

About The George Institute for Global Health 
The George Institute for Global Health conducts clinical, population and health system research aimed at changing health practice and policy worldwide. The Institute has a global network of medical and health experts working together to address the leading causes of death and disability. Established in Australia and affiliated with UNSW Sydney, the Institute today also has offices in China, India and the United Kingdom. The George Institute UK was established in 2010 in partnership with the University of Oxford.

Facebook at thegeorgeinstitute Twitter @georgeinstitute Web georgeinstitute.org